Intracoronary infusion of autologous CD133+ cells in myocardial infarction and tracing by Tc99m MIBI scintigraphy of the heart areas involved in cell homing

Stem Cells International

Volumn , Issue , 2013, Pages

  Kurbonov, Ubaidullo ^a   Dustov, Abdusamad ^b   Barotov, Alisher ^c   Khidirov, Murtazokul ^a   Mirojov, Giesidin ^b   Rahimov, Zikrie ^c   Navjuvonov, Navjuvon ^c   Rizoev, Eraj ^c   Olimov, Nasim ^c   Goibov, Alijon ^a   Karim Zade, Bakhtovar ^a   Rakhmatov, Mukim ^c   Muminjonov, Suhayli ^a   Didari, Azadeh ^a   Irgasheva, Jamila ^a   Bobokhojaev, Oktam ^c   Gulmuradov, Tashpulat ^c   Therwath, Amu ^d   Rakhmonov, Sohibnazar ^c   Mirshahi, Massoud ^a,d  

^a Avicenna Tajik State Medical University   (Tajikistan)

^b Institute of Gastroenterology   (Tajikistan)

^c Tajikistan HIV/AIDS Center   (Tajikistan)

^d CENTRE DE RECHERCHE DES CORDELIERS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGOUTI RELATED PROTEIN; AMPHIREGULIN; ANGIOGENIN; ANGIOPOIETIN 2; BRAIN DERIVED NEUROTROPHIC FACTOR; CARDIOTROPHIN 1; CCL1 CHEMOKINE; CILIARY NEUROTROPHIC FACTOR; COLLAGENASE 3; FIBROBLAST GROWTH FACTOR 2; GELATINASE B; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERSTITIAL COLLAGENASE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE MIGRATION INHIBITION FACTOR; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUROTROPHIN 3; NEUROTROPHIN 4; PLACENTAL GROWTH FACTOR; RANTES; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 4; VASCULOTROPIN 121; VASCULOTROPIN 165; VASCULOTROPIN D;

ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW; CD133+ BONE MARROW MONONUCLEAR CELL; CELL HOMING; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HEART; HEART INFARCTION SIZE; HEART MUSCLE; HEART MUSCLE FIBROSIS; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; INTRACORONARY DRUG ADMINISTRATION; ISCHEMIC HEART DISEASE; LEFT CORONARY ARTERY; MONONUCLEAR CELL; MYOCARDIAL PERFUSION IMAGING; PRIORITY JOURNAL; RIGHT CORONARY ARTERY; SCAR; TREATMENT RESPONSE;

EID: 84883303084     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2013/582527     Document Type: Article

References (22)

1. Wagers A. J., Conboy I. M., Cellular and molecular signatures of muscle regeneration: current concepts and controversies in adult myogenesis. Cell 2005 122 5 659 667 2-s2.0-24144489118 10.1016/j.cell.2005.08.021 (Pubitemid 41242632)
2. Shi X., Garry D. J., Muscle stem cells in development, regeneration, and disease. Genes and Development 2006 20 13 1692 1708 2-s2.0-33745625628 10.1101/gad.1419406 (Pubitemid 43992877)
3. Leri A., Kajstura J., Anversa P., Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology. Circulation Research 2011 109 8 941 961 10.1161/CIRCRESAHA.111.243154
4. Abdel-Latif A., Bolli R., Tleyjeh I. M., Montori V. M., Perin E. C., Hornung C. A., Zuba-Surma E. K., Al-Mallah M., Dawn B., Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Archives of Internal Medicine 2007 167 10 989 997 2-s2.0-33947305414 10.1001/archinte.167.10.989 (Pubitemid 46835786)
5. Hoover-Plow J., Gong Y., Challenges for heart disease stem cell therapy. Journal of Vascular Health and Risk Management 2012 8 99 113 10.2147/VHRM.S25665
6. Segers V. F., Lee R. T., Stem-cell therapy for cardiac disease. Nature 2008 451 7181 937 942 10.1038/nature06800 (Pubitemid 351301749)
7. Aicher A., Heeschen C., Sasaki K. I., Urbich C., Zeiher A. M., Dimmeler S., Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia. Circulation 2006 114 25 2823 2830 2-s2.0-33845891327 10.1161/CIRCULATIONAHA.106.628623 (Pubitemid 46018285)
8. Hofmann M., Wollert K. C., Meyer G. P., Menke A., Arseniev L., Hertenstein B., Ganser A., Knapp W. H., Drexler H., Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 2005 111 17 2198 2202 2-s2.0-18244401368 10.1161/01.CIR.0000163546.27639.AA (Pubitemid 40632435)
9. Liao R., Pfister O., Jain M., Mouquet F., The bone marrow-cardiac axis of myocardial regeneration. Progress in Cardiovascular Diseases 2007 50 1 18 30 2-s2.0-34447303340 10.1016/j.pcad.2007.03.001 (Pubitemid 47049720)
10. Thiele J., Varus E., Wickenhauser C., Kvasnicka H. M., Lorenzen J., Gramley F., Metz K. A., Rivero F., Beelen D. W., Mixed chimerism of cardiomyocytes and vessels after allogeneic bone marrow and stem-cell transplantation in comparison with cardiac allografts. Transplantation 2004 77 12 1902 1905 2-s2.0-3042564142 10.1097/01.TP.0000127591.34203.8E (Pubitemid 38822217)
11. Agbulut O., Vandervelde S., Al Attar N., Larghero J., Ghostine S., Léobon B., Robidel E., Borsani P., Le Lorc'H M., Bissery A., Chomienne C., Bruneval P., Marolleau J. P., Vilquin J. T., Hagège A., Samuel J. L., Menasché P., Comparison of human skeletal myoblasts and bone marrow-derived CD133+ progenitors for the repair of infarcted myocardium. Journal of the American College of Cardiology 2004 44 2 458 463 2-s2.0-3242712312 10.1016/j.jacc.2004.03.083 (Pubitemid 38950611)
12. Taylor D. A., Atkins B. Z., Hungspreugs P., Jones T. R., Reedy M. C., Hutcheson K. A., Glower D. D., Kraus W. E., Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nature Medicine 1998 4 8 929 933. Erratum in Nature Medicine, vol. 4, no. 10, pp. 1200, 1998 2-s2.0-0031928026 10.1038/nm0898-929 (Pubitemid 28364032)
13. Stamm C., Westphal B., Kleine H. D., Petzsch M., Kittner C., Klinge H., Schümichen C., Nienaber C. A., Freund M., Steinhoff G., Autologous bone-marrow stem-cell transplantation for myocardial regeneration. The Lancet 2003 361 9351 45 46 2-s2.0-0037417501 10.1016/S0140-6736(03)12110-1 (Pubitemid 36050962)
14. Beeres S. L. M. A., Bengel F. M., Bartunek J., Atsma D. E., Hill J. M., Vanderheyden M., Penicka M., Schalij M. J., Wijns W., Bax J. J., Role of imaging in cardiac stem cell therapy. Journal of the American College of Cardiology 2007 49 11 1137 1148 2-s2.0-33947141093 10.1016/j.jacc.2006.10.072 (Pubitemid 46400333)
15. Tondreau T., Meuleman N., Delforge A., Dejeneffe M., Leroy R., Massy M., Mortier C., Bron D., Lagneaux L., Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells 2005 23 8 1105 1112 2-s2.0-25444432287 10.1634/stemcells.2004-0330 (Pubitemid 41377726)
16. Jougasaki M., Cardiotrophin-1 in cardiovascular regulation. Advances in Clinical Chemistry 2010 52 41 76 2-s2.0-77957000714 10.1016/S0065-2423(10)52002- X
17. Lohela M., Bry M., Tammela T., Alitalo K., VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Current Opinion in Cell Biology 2009 21 2 154 165 2-s2.0-63749125392 10.1016/j.ceb.2008.12.012
18. Wilson K. J., Mill C., Lambert S., EGFR ligands exhibit functional differences in models of paracrine and autocrine signaling. Growth Factors 2012 30 2 107 116 10.3109/08977194.2011.649918
19. Park H., Poo M. M., Neurotrophin regulation of neural circuit development and function. Nature Reviews Neuroscience 2012 14 1 7 23 10.1038/nrn3379
20. van Wijk B., Moorman A. F. M., van den Hoff M. J. B., Role of bone morphogenetic proteins in cardiac differentiation. Cardiovascular Research 2007 74 2 244 255 2-s2.0-34047098378 10.1016/j.cardiores.2006.11.022 (Pubitemid 46517505)
21. Wan M., Cao X., BMP signaling in skeletal development. Biochemical and Biophysical Research Communications 2005 328 3 651 657 2-s2.0-13444291335 10.1016/j.bbrc.2004.11.067 (Pubitemid 40208302)
22. Sun Y., Fei T., Yang T., Zhang F., Chen Y. G., Li H., Xu Z., The suppression of CRMP2 expression by Bone Morphogenetic Protein (BMP)-SMAD gradient signaling controls multiple stages of neuronal development. The Journal of Biological Chemistry 2010 285 50 39039 39050 2-s2.0-78649876724 10.1074/jbc.M110.168351